2019
DOI: 10.1016/j.athoracsur.2018.11.022
|View full text |Cite
|
Sign up to set email alerts
|

Association Between Red Blood Cell Transfusion and Clinical Outcomes Among Patients Undergoing Transcatheter Aortic Valve Replacement

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

3
5
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 11 publications
(8 citation statements)
references
References 29 publications
3
5
0
Order By: Relevance
“…6 On the other hand, the STS/ACC TVT Registry does not include TAVR procedures performed as part of investigational device exemption trials, and previous studies have shown lower rates of transfusion in clinical trial populations. 7,8 Finally, the results of our current study using the National Inpatient Sample (NIS) database 2 are consistent with findings from a single-center study 9 as well as the STS/ACC TVT Registry, 10 both of which also demonstrated that RBC transfusion was associated with worse outcomes in patients undergoing TAVR. Thus, despite the modest sensitivity of ICD-9-CM codes for RBC transfusion, we believe that the results of our propensity-matched analysis with the NIS database are reliable and provide important insights into the association between RBC transfusion and outcomes in patients undergoing TAVR.…”
supporting
confidence: 85%
“…6 On the other hand, the STS/ACC TVT Registry does not include TAVR procedures performed as part of investigational device exemption trials, and previous studies have shown lower rates of transfusion in clinical trial populations. 7,8 Finally, the results of our current study using the National Inpatient Sample (NIS) database 2 are consistent with findings from a single-center study 9 as well as the STS/ACC TVT Registry, 10 both of which also demonstrated that RBC transfusion was associated with worse outcomes in patients undergoing TAVR. Thus, despite the modest sensitivity of ICD-9-CM codes for RBC transfusion, we believe that the results of our propensity-matched analysis with the NIS database are reliable and provide important insights into the association between RBC transfusion and outcomes in patients undergoing TAVR.…”
supporting
confidence: 85%
“…6 On the other hand, the STS/ACC TVT Registry does not include TAVR procedures performed as part of investigational device exemption trials, and previous studies have shown lower rates of transfusion in clinical trial populations. 7,8 Finally, the results of our current study using the National Inpatient Sample (NIS) database 2 are consistent with findings from a single-center study 9 as well as the STS/ACC TVT Registry, 10 both of which also demonstrated that RBC transfusion was associated with worse outcomes in patients undergoing TAVR. Thus, despite the modest sensitivity of ICD-9-CM codes for RBC transfusion, we believe that the results of our propensity-matched analysis with the NIS database are reliable and provide important insights into the association between RBC transfusion and outcomes in patients undergoing TAVR.…”
supporting
confidence: 83%
“…Previous studies documented rates of blood transfusion after TAVR of 25% to 39% in series with a prevalence of anemia ranging from 45% to 57%. [5][6][7][8] The present study documented a rate of RBC transfusion of 16% in the context of a prevalence of anemia of 46%. These figures suggested that, despite a lack of a policy of preoperative optimization of hemoglobin, in this nationwide series the risk of severe bleeding requiring transfusion was rather low and decreased over time.…”
Section: Discussionmentioning
confidence: 52%
“…The negative prognostic effect of blood transfusion has been largely demonstrated in cardiac surgery, 22 whereas only a few studies of small size investigated this issue in patients undergoing TAVR. [4][5][6][7][8]23,24 This setting provides important advantages in investigating the effect of transfusions in patients undergoing cardiovascular interventions. Indeed, the minimally invasive nature of TAVR allows a more reliable evaluation of the effects of perioperative anemia and blood transfusion without the confounding effect of significant hemodilution and other detrimental effects of cardiopulmonary bypass seen in patients undergoing cardiac surgery.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation